|
|
|
|
|
|
|
|
"The risks of subsequent contralateral breast cancer are substantial for women who carry a BRCA1/BRCA2 mutation. These findings have important clinical relevance regarding the assessment of BRCA1/BRCA2 status in patients with breast cancer and the counseling and clinical management of patients found to carry a mutation."
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.